{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T14:36:45Z","timestamp":1792507005758,"version":"4.5.0"},"reference-count":35,"publisher":"Walter de Gruyter GmbH","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,8,27]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec id=\"j_cclm-2019-0869_s_999\">\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>Liquid chromatography-tandem mass spectrometry (LC-MS\/MS)-based assays are employed in more and more clinical laboratories to quantify steroids. The steroid quantification by LC-MS\/MS shows great value in screening or diagnosing endocrine disorders; however, the number of functional steroids included in the LC-MS\/MS methods is still limited.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec id=\"j_cclm-2019-0869_s_998\">\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>Here, we describe the performance and validation of a 20-steroid plasma panel by LC-MS\/MS. The panel included progestogens (including mineralocorticoids and glucocorticoids), androgens and estrogens biosynthesized in steroid metabolic pathways. The LC-MS\/MS method was validated according to guidance documents, and subsequently employed to profile steroid changes in endocrine disorders.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec id=\"j_cclm-2019-0869_s_997\">\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Using LC-MS\/MS, 20 steroids were separated and quantified in 8 min. Coefficients of variation (CVs) of the 20 analytes at the lower limit of quantification (LLoQ) were all less than 15% (ranging from 1.84% to 14.96%). The linearity of the assay was demonstrated by all the R<jats:sup>2<\/jats:sup> values greater than 0.995. Individual plasma steroids changed significantly in patients with subclinical Cushing\u2019s syndrome (SCS) and polycystic ovary syndrome (PCOS) \u2013 17-hydroxypregnenolone (17-OH-PR), testosterone (T) and dihydrotestosterone (DHT) were significantly decreased in SCS patients, while in PCOS patients, pregnenolone, corticosterone (CORT), androstenedione (A4) and T were significantly increased and DHT was decreased.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec id=\"j_cclm-2019-0869_s_996\">\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>The LC-MS\/MS method we developed for the quantification of 20 plasma steroids is clinical practicable. The steroid profiling data using this assay indicate its screening value for endocrine disorders. To further explore the value of the assay, more investigations are however needed.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1515\/cclm-2019-0869","type":"journal-article","created":{"date-parts":[[2020,2,21]],"date-time":"2020-02-21T09:02:00Z","timestamp":1582275720000},"page":"1477-1487","source":"Crossref","is-referenced-by-count":66,"title":["A liquid chromatography-tandem mass spectrometry (LC-MS\/MS)-based assay to profile 20 plasma steroids in endocrine disorders"],"prefix":"10.1515","volume":"58","author":[{"given":"Zhenxin","family":"Wang","sequence":"first","affiliation":[{"name":"Department of Laboratory Medicine, Zhongshan Hospital , Fudan University , Shanghai , P.R. China"},{"name":"Institute of Biomedical Science , Fudan University , Shanghai , P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6881-9977","authenticated-orcid":false,"given":"Hao","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Shanghai Institute of Cardiovascular Diseases, Department of Laboratory Medicine, Zhongshan Hospital , Fudan University , Shanghai , P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingfei","family":"Peng","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine, Zhongshan Hospital , Fudan University , Shanghai , P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6888-4517","authenticated-orcid":false,"given":"Fangjun","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine, Zhongshan Hospital , Fudan University , Shanghai , P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Zhao","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism, Fudan Institute of Metabolic Diseases, Zhongshan Hospital , Fudan University , Shanghai , P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8337-0207","authenticated-orcid":false,"given":"Xiaomu","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism, Fudan Institute of Metabolic Diseases, Zhongshan Hospital , Fudan University , Shanghai , P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaqian","family":"Qin","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine, Zhongshan Hospital , Fudan University , Shanghai , P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qianqian","family":"Li","sequence":"additional","affiliation":[{"name":"Waters Technologies (Shanghai) Co., Ltd., Pudong New District , Shanghai , P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beili","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine, Zhongshan Hospital , Fudan University , Shanghai , P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baishen","family":"Pan","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine, Zhongshan Hospital , Fudan University , Shanghai , P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Guo","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine, Zhongshan Hospital , Fudan University , Shanghai , P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"374","published-online":{"date-parts":[[2020,2,21]]},"reference":[{"key":"2023033110401809170_j_cclm-2019-0869_ref_001","doi-asserted-by":"crossref","unstructured":"Zografos GN, Perysinakis I, Vassilatou E. Subclinical Cushing\u2019s syndrome: current concepts and trends. Hormones (Athens) 2014;13:323\u201337.","DOI":"10.14310\/horm.2002.1506"},{"key":"2023033110401809170_j_cclm-2019-0869_ref_002","doi-asserted-by":"crossref","unstructured":"Tsinberg M, Liu C, Duh QY. Subclinical Cushing\u2019s syndrome. J Surg Oncol 2012;106:572\u20134.","DOI":"10.1002\/jso.23143"},{"key":"2023033110401809170_j_cclm-2019-0869_ref_003","doi-asserted-by":"crossref","unstructured":"Plenis A, Baczek T. Quantification of the salivary steroid hormones considered as bio-markers in clinical research studies and sports medicine. Curr Pharm Anal 2010;6:182\u201397.","DOI":"10.2174\/157341210791936812"},{"key":"2023033110401809170_j_cclm-2019-0869_ref_004","doi-asserted-by":"crossref","unstructured":"Janzen N, Peter M, Sander S, Steuerwald U, Terhardt M, Holtkamp U, et al. Newborn screening for congenital adrenal hyperplasia: additional steroid profile using liquid chromatography-tandem mass spectrometry. J Clin Endocrinol Metab 2007;92:2581\u20139.","DOI":"10.1210\/jc.2006-2890"},{"key":"2023033110401809170_j_cclm-2019-0869_ref_005","doi-asserted-by":"crossref","unstructured":"Monostori P, Szabo P, Marginean O, Bereczki C, Karg E. Concurrent confirmation and differential diagnosis of congenital adrenal hyperplasia from dried blood spots: application of a second-tier LC-MS\/MS assay in a cross-border cooperation for newborn screening. Horm Res Paediatr 2015;84:311\u20138.","DOI":"10.1159\/000439380"},{"key":"2023033110401809170_j_cclm-2019-0869_ref_006","doi-asserted-by":"crossref","unstructured":"Eisenhofer G, Dekkers T, Peitzsch M, Dietz AS, Bidlingmaier M, Treitl M, et al. Mass spectrometry-based adrenal and peripheral venous steroid profiling for subtyping primary aldosteronism. Clin Chem 2016;62:514\u201324.","DOI":"10.1373\/clinchem.2015.251199"},{"key":"2023033110401809170_j_cclm-2019-0869_ref_007","doi-asserted-by":"crossref","unstructured":"Peitzsch M, Dekkers T, Haase M, Sweep FC, Quack I, Antoch G, et al. An LC-MS\/MS method for steroid profiling during adrenal venous sampling for investigation of primary aldosteronism. J Steroid Biochem Mol Biol 2015;145:75\u201384.","DOI":"10.1016\/j.jsbmb.2014.10.006"},{"key":"2023033110401809170_j_cclm-2019-0869_ref_008","doi-asserted-by":"crossref","unstructured":"Di Dalmazi G, Fanelli F, Mezzullo M, Casadio E, Rinaldi E, Garelli S, et al. Steroid profiling by LC-MS\/MS in nonsecreting and subclinical cortisol-secreting adrenocortical adenomas. J Clin Endocrinol Metab 2015;100:3529\u201338.","DOI":"10.1210\/JC.2015-1992"},{"key":"2023033110401809170_j_cclm-2019-0869_ref_009","doi-asserted-by":"crossref","unstructured":"Lynch KL. CLSI C62-A: a new standard for clinical mass spectrometry. Clin Chem 2016;62:24\u20139.","DOI":"10.1373\/clinchem.2015.238626"},{"key":"2023033110401809170_j_cclm-2019-0869_ref_010","unstructured":"Chinese Society of Laboratory Medicine NCfCL. Recommendations of liquid chromatography-mass spectrometry clinical applicationc in China. Chin J Lab Med 2017;40:770\u20139 [in Chinese]."},{"key":"2023033110401809170_j_cclm-2019-0869_ref_011","doi-asserted-by":"crossref","unstructured":"Inder WJ. Towards a universally accepted definition of subclinical Cushing\u2019s syndrome \u2013 subclinical autonomous hypercortisolism. Clin Endocrinol (Oxf) 2017;86:7\u20139.","DOI":"10.1111\/cen.13244"},{"key":"2023033110401809170_j_cclm-2019-0869_ref_012","doi-asserted-by":"crossref","unstructured":"Rotterdam EA-SPCWG. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril 2004;81:19\u201325.","DOI":"10.1016\/j.fertnstert.2003.10.004"},{"key":"2023033110401809170_j_cclm-2019-0869_ref_013","doi-asserted-by":"crossref","unstructured":"Evans DA. History of the Harvard ChemDraw project. Angew Chem Int Ed Engl 2014;53:11140\u20135.","DOI":"10.1002\/anie.201405820"},{"key":"2023033110401809170_j_cclm-2019-0869_ref_014","doi-asserted-by":"crossref","unstructured":"Fong BM, Tam S, Leung KS. Improved liquid chromatography-tandem mass spectrometry method in clinical utility for the diagnosis of Cushing\u2019s syndrome. Anal Bioanal Chem 2010;396:783\u201390.","DOI":"10.1007\/s00216-009-3247-1"},{"key":"2023033110401809170_j_cclm-2019-0869_ref_015","doi-asserted-by":"crossref","unstructured":"Hamer HM, Finken MJ, van Herwaarden AE, du Toit T, Swart AC, Heijboer AC. Falsely elevated plasma testosterone concentrations in neonates: importance of LC-MS\/MS measurements. Clin Chem Lab Med 2018;56:E141\u20133.","DOI":"10.1515\/cclm-2017-1028"},{"key":"2023033110401809170_j_cclm-2019-0869_ref_016","doi-asserted-by":"crossref","unstructured":"Koal T, Schmiederer D, Pham-Tuan H, Rohring C, Rauh M. Standardized LC-MS\/MS based steroid hormone profile-analysis. J Steroid Biochem Mol Biol 2012;129:129\u201338.","DOI":"10.1016\/j.jsbmb.2011.12.001"},{"key":"2023033110401809170_j_cclm-2019-0869_ref_017","doi-asserted-by":"crossref","unstructured":"Rauh M. Steroid measurement with LC-MS\/MS in pediatric endocrinology. Mol Cell Endocrinol 2009;301:272\u201381.","DOI":"10.1016\/j.mce.2008.10.007"},{"key":"2023033110401809170_j_cclm-2019-0869_ref_018","doi-asserted-by":"crossref","unstructured":"Taylor DR, Ghataore L, Couchman L, Vincent RP, Whitelaw B, Lewis D, et al. A 13-Steroid serum panel based on LC-MS\/MS: use in detection of adrenocortical carcinoma. Clin Chem 2017;63:1836\u201346.","DOI":"10.1373\/clinchem.2017.277624"},{"key":"2023033110401809170_j_cclm-2019-0869_ref_019","doi-asserted-by":"crossref","unstructured":"Hines JM, Bancos I, Bancos C, Singh RD, Avula AV, Young WF, et al. High-resolution, accurate-mass (HRAM) mass spectrometry urine steroid profiling in the diagnosis of adrenal disorders. Clin Chem 2017;63:1824\u201335.","DOI":"10.1373\/clinchem.2017.271106"},{"key":"2023033110401809170_j_cclm-2019-0869_ref_020","doi-asserted-by":"crossref","unstructured":"Gaudl A, Kratzsch J, Bae YJ, Kiess W, Thiery J, Ceglarek U. Liquid chromatography quadrupole linear ion trap mass spectrometry for quantitative steroid hormone analysis in plasma, urine, saliva and hair. J Chromatogr A 2016;1464:64\u201371.","DOI":"10.1016\/j.chroma.2016.07.087"},{"key":"2023033110401809170_j_cclm-2019-0869_ref_021","doi-asserted-by":"crossref","unstructured":"Chiodini I, Albani A, Ambrogio AG, Campo M, De Martino MC, Marcelli G, et al. Six controversial issues on subclinical Cushing\u2019s syndrome. Endocrine 2017;56:262\u20136.","DOI":"10.1007\/s12020-016-1017-3"},{"key":"2023033110401809170_j_cclm-2019-0869_ref_022","doi-asserted-by":"crossref","unstructured":"Soszynski P, Stowinska-Srzednicka J, Kasperlik-Zatuska A, Zgliczynski S. Decreased melatonin concentration in Cushing\u2019s syndrome. Horm Metab Res 1989;21:673\u20134.","DOI":"10.1055\/s-2007-1009317"},{"key":"2023033110401809170_j_cclm-2019-0869_ref_023","doi-asserted-by":"crossref","unstructured":"Nawata H, Higuchi K, Yanase T, Takayanagi R, Kato K, IbayashiH. Mechanism of dissociation of cortisol and adrenal androgen secretion after removal of adrenocortical adenoma in patients with Cushing\u2019s syndrome. Endocrinol Jpn 1985;32:691\u2013700.","DOI":"10.1507\/endocrj1954.32.691"},{"key":"2023033110401809170_j_cclm-2019-0869_ref_024","doi-asserted-by":"crossref","unstructured":"Fassnacht M, Arlt W, Bancos I, Dralle H, Newell-Price J, Sahdev A, et al. Management of adrenal incidentalomas: European Society of Endocrinology Clinical Practice Guideline in collaboration with the European Network for the Study of Adrenal Tumors. Eur J Endocrinol 2016;175:G1\u201334.","DOI":"10.1530\/EJE-16-0467"},{"key":"2023033110401809170_j_cclm-2019-0869_ref_025","doi-asserted-by":"crossref","unstructured":"Cao C, Yang X, Li L, Sun R, Xian Y, Lv W, et al. Increased expression of CYP17 and CYP11B1 in subclinical Cushing\u2019s syndrome due to adrenal adenomas. Int J Urol 2011;18:691\u20136.","DOI":"10.1111\/j.1442-2042.2011.02836.x"},{"key":"2023033110401809170_j_cclm-2019-0869_ref_026","doi-asserted-by":"crossref","unstructured":"Fang Y. Editorial comment from Dr Fang to increased expression of CYP17 and CYP11B1 in subclinical Cushing\u2019s syndrome due to adrenal adenomas. Int J Urol 2011;18:697\u20139.","DOI":"10.1111\/j.1442-2042.2011.02843.x"},{"key":"2023033110401809170_j_cclm-2019-0869_ref_027","doi-asserted-by":"crossref","unstructured":"Ishidoya S. Editorial comment from Dr Ishidoya to increased expression of CYP17 and CYP11B1 in subclinical Cushing\u2019s syndrome due to adrenal adenomas. Int J Urol 2011;18:697.","DOI":"10.1111\/j.1442-2042.2011.02840.x"},{"key":"2023033110401809170_j_cclm-2019-0869_ref_028","doi-asserted-by":"crossref","unstructured":"Goodarzi MO, Carmina E, Azziz R. DHEA, DHEAS and PCOS. J Steroid Biochem Mol Biol 2015;145:213\u201325.","DOI":"10.1016\/j.jsbmb.2014.06.003"},{"key":"2023033110401809170_j_cclm-2019-0869_ref_029","doi-asserted-by":"crossref","unstructured":"Blumenfeld Z, Kaidar G, Zuckerman-Levin N, Dumin E, Knopf C, Hochberg Z. Cortisol-metabolizing enzymes in polycystic ovary syndrome. Clin Med Insights Reprod Health 2016;10:9\u201313.","DOI":"10.4137\/CMRH.S35567"},{"key":"2023033110401809170_j_cclm-2019-0869_ref_030","doi-asserted-by":"crossref","unstructured":"Gagliano-Juca T, Tang ER, Bhasin S, Pencina KM, Anderson S, Jara H, et al. Effects of testosterone administration (and its 5-alpha-reduction) on parenchymal organ volumes in healthy young men: findings from a dose-response trial. Andrology 2017;5:889\u201397.","DOI":"10.1111\/andr.12392"},{"key":"2023033110401809170_j_cclm-2019-0869_ref_031","doi-asserted-by":"crossref","unstructured":"Wang LH, Li SX, Zhao AM, Tao T, Mao XY, Zhang P, et al. The expression of sex steroid synthesis and inactivation enzymes in subcutaneous adipose tissue of PCOS patients. J Steroid Biochem Mol Biol 2012;132:120\u20136.","DOI":"10.1016\/j.jsbmb.2012.02.003"},{"key":"2023033110401809170_j_cclm-2019-0869_ref_032","doi-asserted-by":"crossref","unstructured":"Audet-Walsh E, Yee T, Tam IS, Giguere V. Inverse regulation of DHT synthesis enzymes 5alpha-reductase types 1 and 2 by the androgen receptor in prostate cancer. Endocrinology 2017;158:1015\u201321.","DOI":"10.1210\/en.2016-1926"},{"key":"2023033110401809170_j_cclm-2019-0869_ref_033","doi-asserted-by":"crossref","unstructured":"Handelsman DJ, Teede HJ, Desai R, Norman RJ, Moran LJ. Performance of mass spectrometry steroid profiling for diagnosis of polycystic ovary syndrome. Human Reproduction 2017;32:1540.","DOI":"10.1093\/humrep\/dex212"},{"key":"2023033110401809170_j_cclm-2019-0869_ref_034","doi-asserted-by":"crossref","unstructured":"O\u2019Reilly MW, Taylor AE, Crabtree NJ, Hughes BA, Capper F, Crowley RK, et al. Hyperandrogenemia predicts metabolic phenotype in polycystic ovary syndrome: the utility of serum androstenedione. J Clin Endocrinol Metab 2014;99:1027\u201336.","DOI":"10.1210\/jc.2013-3399"},{"key":"2023033110401809170_j_cclm-2019-0869_ref_035","doi-asserted-by":"crossref","unstructured":"Salameh WA, Redor-Goldman MM, Clarke NJ, Mathur R, Azziz R, Reitz RE. Specificity and predictive value of circulating testosterone assessed by tandem mass spectrometry for the diagnosis of polycystic ovary syndrome by the National Institutes of Health 1990 criteria. Fertil Steril 2015;103:299.","DOI":"10.1016\/j.fertnstert.2013.12.056"}],"container-title":["Clinical Chemistry and Laboratory Medicine (CCLM)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.degruyter.com\/view\/journals\/cclm\/58\/9\/article-p1477.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.degruyter.com\/document\/doi\/10.1515\/cclm-2019-0869\/xml","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.degruyter.com\/document\/doi\/10.1515\/cclm-2019-0869\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,31]],"date-time":"2023-03-31T12:43:08Z","timestamp":1680266588000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.degruyter.com\/document\/doi\/10.1515\/cclm-2019-0869\/html"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2,21]]},"references-count":35,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2020,7,15]]},"published-print":{"date-parts":[[2020,8,27]]}},"alternative-id":["10.1515\/cclm-2019-0869"],"URL":"https:\/\/doi.org\/10.1515\/cclm-2019-0869","relation":{},"ISSN":["1434-6621","1437-4331"],"issn-type":[{"value":"1434-6621","type":"print"},{"value":"1437-4331","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,2,21]]}}}